Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines, vaccines franchises, support, and corporate functions 1973 and is headquartered in Paris, France.

CEO

Belén Garijo López

CEOBelén Garijo López

Employees

76,493

Employees76,493

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1973

Founded1973

Employees

76,493

Employees76,493

SNY Key Statistics

Market cap

100.47B

Market cap100.47B

Price-Earnings ratio

21.33

Price-Earnings ratio21.33

Dividend yield

4.24%

Dividend yield4.24%

Average volume

3.84M

Average volume3.84M

High today

$41.75

High today$41.75

Low today

$41.25

Low today$41.25

Open price

$41.70

Open price$41.70

Volume

2.01M

Volume2.01M

52 Week high

$52.68

52 Week high$52.68

52 Week low

$39.07

52 Week low$39.07

SNY News

TipRanks 2d

Sanofi’s New Oral Alzheimer’s Drug Enters Mid-Stage Trials: What Investors Should Watch

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi is running a mid-stage study called “A Phase 2, Randomized, Double-blind, Placebo-c...

TipRanks 2d

Sanofi Advances Rilzabrutinib Kidney Study, Supporting Long-Term BTK Pipeline Potential

Sanofi SA (SNY) announced an update on their ongoing clinical study. The Phase 1 study “An Open-label, Multi-center, Phase 1 Pharmacokinetic and Tolerability S...

TipRanks 3d

Sanofi Shuts Down Long-Term IBD Drug Study, Nudging Expectations for Future Growth

Sanofi (SNYNF) announced an update on their ongoing clinical study. Sanofi has ended a multinational extension study called SPECIFI-IBD-LTS, which tracked long...

Analyst ratings

50%

of 10 ratings

Buy

50%

Hold

50%

Sell

More SNY News

TipRanks 5d

Sanofi, ScionxBio enter collaboration, licensing agreement

ScionxBio has entered into a worldwide strategic collaboration and licensing agreement with Sanofi (SNY) to develop and commercialize extended exposure versions...

Simply Wall St 6d

Why Is Recursion Pharmaceuticals Drawing Attention After AI Drug And Trial Milestones?

Recursion Pharmaceuticals (NasdaqGS:RXRX) and Sanofi announced that Sanofi has optioned the first AI-discovered development candidate from their partnership, tr...

TipRanks 6d

Sanofi’s Rilzabrutinib DDI Study Signals Steady Progress In BTK Pipeline

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi SA (SNY) is running a Phase 1 drug interaction study in healthy volunteers to bette...

TipRanks 6d

Sanofi’s China Vaccine Trial Nears Data Reveal: What Investors Should Watch

Sanofi (SNYNF) announced an update on their ongoing clinical study. Sanofi’s latest phase 3 study looks at a new four-strain meningococcal vaccine in healthy c...

TipRanks 6d

Sanofi Breaks Ground on Major AI-Enabled Insulin Plant in Frankfurt

Sanofi ( (FR:SAN) ) has issued an announcement. Sanofi has laid the foundation stone for a new state-of-the-art insulin production unit at its BioCampus in Fra...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.